Filters
In early postmenopausal women, intravenous infusions of zoledronate once every 5 years could help reduce the risk of vertebral fractures, according to a recent study.
A study from Singapore shows that targeted therapies such as bevacizumab, immune checkpoint inhibitors (ICIs), and secondary cytoreductive surgery (SCS) hold promise for the treatment of ovarian clear cell carcinoma (OCCC).
New drug applications approved by US FDA as of 16-31 January 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
A novel vaccine that targets HPV type 16 (HPV16) has shown clinical activity against HPV16-positive cervical intraepithelial neoplasia grade 3 (CIN3) in a phase II trial, substantially reducing lesion size.
Underweight or obesity during adolescence may contribute to unexplained infertility later in life, as suggested in a large study involving Japanese women.
Herbal intervention with Matricaria chamomilla, known as chamomile, appears to alleviate menopausal symptoms, as shown in the results of a triple-blind clinical trial.
Early menarche is significantly associated with a higher chance of developing hypertension, specifically in women of reproductive age, suggests a study.
Researchers from Singapore have found a whole blood-based DNA methylation biomarker profile that effectively distinguishes breast cancer patients from healthy controls.
Cardiovascular (CV) events during pregnancy appear to moderately increase the risk of adverse pregnancy outcomes (APOs), such as preterm birth, small for gestational age (SGA), or both, reports a recent study.
Individuals already taking pre-exposure prophylaxis (PrEP) for HIV prevention saw sharp declines in chlamydia and syphilis cases, as well as a moderate reduction in urethral and rectal gonorrhoea, when they also took doxycycline after potential exposure (doxyPEP).
